These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 1805211)

  • 21. Fasciola hepatica: tegumental changes induced in vitro by the deacetylated (amine) metabolite of diamphenethide.
    Fairweather I; Anderson HR; Threadgold LT
    Exp Parasitol; 1986 Dec; 62(3):336-48. PubMed ID: 3780927
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Time-dependent changes to the tegumental system and gastrodermis of adult Fasciola hepatica following treatment in vivo with triclabendazole in the sheep host.
    Toner E; Brennan GP; Hanna RE; Edgar HW; Fairweather I
    Vet Parasitol; 2010 Dec; 174(3-4):218-27. PubMed ID: 20933333
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of compound alpha treatment in vivo on egg production by the liver fluke, Fasciola hepatica.
    McConville M; Hanna RE; Brennan GP; Edgar HW; McConnell S; McCoy M; Castillo R; Hernández-Campos A; Fairweather I
    Vet Parasitol; 2012 Jun; 187(1-2):183-95. PubMed ID: 22285009
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fasciola gigantica: tegumental surface alterations following treatment in vitro with the sulphoxide metabolite of triclabendazole.
    Meaney M; Fairweather I; Brennan GP; Ramasamy P; Subramanian PB
    Parasitol Res; 2002 Apr; 88(4):315-25. PubMed ID: 11999018
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fasciola hepatica: surface and internal tegumental changes induced by treatment in vitro with the sulphoxide metabolite of albendazole ('Valbazen').
    Buchanan JF; Fairweather I; Brenna GP; Trudgett A; Hoey EM
    Parasitology; 2003 Feb; 126(Pt 2):141-53. PubMed ID: 12636352
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adult triclabendazole-resistant Fasciola hepatica: morphological changes in the tegument and gut following in vivo treatment with artemether in the rat model.
    O'Neill JF; Johnston RC; Halferty L; Brennan GP; Keiser J; Fairweather I
    J Helminthol; 2009 Jun; 83(2):151-63. PubMed ID: 19368748
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relative activity of triclabendazole metabolites against the liver fluke, Fasciola hepatica.
    Halferty L; Brennan GP; Trudgett A; Hoey L; Fairweather I
    Vet Parasitol; 2009 Feb; 159(2):126-38. PubMed ID: 19027238
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fasciola hepatica: Surface tegumental responses to in vitro and in vivo treatment with the experimental fasciolicide OZ78.
    Keiser J; Morson G
    Exp Parasitol; 2008 May; 119(1):87-93. PubMed ID: 18261730
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immature triclabendazole-resistant Fasciola hepatica: tegumental responses to in vitro treatment with the sulphoxide metabolite of the experimental fasciolicide compound alpha.
    McConville M; Brennan GP; McCoy M; Castillo R; Hernandez-Campos A; Ibarra F; Fairweather I
    Parasitol Res; 2007 Jan; 100(2):365-77. PubMed ID: 17016729
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fasciola hepatica: tegumental alterations in adult flukes following in vitro and in vivo administration of artesunate and artemether.
    Keiser J; Morson G
    Exp Parasitol; 2008 Feb; 118(2):228-37. PubMed ID: 17888906
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Piperonyl butoxide enhances triclabendazole action against triclabendazole-resistant Fasciola hepatica.
    Devine C; Brennan GP; Lanusse CE; Alvarez LI; Trudgett A; Hoey E; Fairweather I
    Parasitology; 2011 Feb; 138(2):224-36. PubMed ID: 20946692
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tegumental surface changes in juvenile Fasciola hepatica in response to treatment in vivo with triclabendazole.
    Halferty L; Brennan GP; Hanna RE; Edgar HW; Meaney MM; McConville M; Trudgett A; Hoey L; Fairweather I
    Vet Parasitol; 2008 Aug; 155(1-2):49-58. PubMed ID: 18511199
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ultrastructural changes to the tegumental system and gastrodermal cells of adult Fasciola hepatica following treatment in vivo with a commercial preparation of myrrh (Mirazid).
    Abdelaal MMO; Brennan GP; Abdel-Aziz A; Fairweather I
    J Helminthol; 2017 Nov; 91(6):672-685. PubMed ID: 27762182
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased action of triclabendazole (TCBZ) in vitro against a TCBZ-resistant isolate of Fasciola hepatica following its co-incubation with the P-glycoprotein inhibitor, R(+)-verapamil.
    Savage J; Meaney M; Brennan GP; Hoey E; Trudgett A; Fairweather I
    Exp Parasitol; 2013 Nov; 135(3):642-53. PubMed ID: 24090567
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tegumental surface changes in adult Fasciola hepatica in response to treatment in vivo with triclabendazole in the sheep host.
    Toner E; Brennan GP; Hanna RE; Edgar HW; Fairweather I
    Vet Parasitol; 2010 Sep; 172(3-4):238-48. PubMed ID: 20627418
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fasciola hepatica: tegumental surface alterations following treatment in vivo and in vitro with nitroxynil (Trodax).
    McKinstry B; Fairweather I; Brennan GP; Forbes AB
    Parasitol Res; 2003 Oct; 91(3):251-63. PubMed ID: 12937960
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Light and electron microscopic studies on the effect of praziquantel on Schistosoma mansoni, Dicrocoelium dendriticum, and Fasciola hepatica (Trematoda) in vitro.
    Becker B; Mehlhorn H; Andrews P; Thomas H; Eckert J
    Z Parasitenkd; 1980; 63(2):113-28. PubMed ID: 7456640
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of the vitellaria of the liver fluke, Fasciola hepatica in the rat host.
    Robinson MW; Colhoun LM; Fairweather I; Brennan GP; Waite JH
    Parasitology; 2001 Nov; 123(Pt 5):509-18. PubMed ID: 11719962
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Morphological response of triclabendazole-susceptible and triclabendazole-resistant isolates of Fasciola hepatica to treatment in vitro with nitroxynil (Trodax).
    McKinstry B; Halferty L; Brennan GP; Fairweather I
    Parasitol Res; 2009 Feb; 104(3):645-55. PubMed ID: 19015880
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ultrastructural changes to the tegumental system and the gastrodermal cells in adult Fasciola hepatica following in vivo treatment with the experimental fasciolicide, compound alpha.
    McConville M; Brennan GP; Flanagan A; Edgar HW; Castillo R; Hernández-Campos A; Fairweather I
    Parasitology; 2009 May; 136(6):665-80. PubMed ID: 19368745
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.